ALLMedicine™ Japanese Encephalitis Center
Research & Reviews 925 results
Human Vaccines & Immunotherapeutics; Shoushtari M, Roohvand F et. al.
Jun 18th, 2022 - Flaviviruses are arthropod-borne viruses (arboviruses) that have been recently considered among the significant public health problems in defined geographical regions. In this line, there have been vaccines approved for some flaviviruses including...
The Lancet. Global Health; Pommier JD, Gorman C et. al.
Jun 18th, 2022 - Encephalitis is a worldwide public health issue, with a substantially high burden among children in southeast Asia. We aimed to determine the causes of encephalitis in children admitted to hospitals across the Greater Mekong region by implementing...
https://doi.org/10.1186/s13071-022-05329-0 10.1038/emi.2015.18 10.1186/s13071-017-2559-9 10.3390/v13061154 10.1371/journal.pntd.0002411 10.1016/j.vetmic.2017.01.014 10.3390/v13030357 10.1038/ncomms10832 10.3201/eid1204.051010 10.1093/jtm/tay009 10.1016/j.prevetmed.2018.03.018 10.1016/j.actatropica.2014.02.018 10.2807/ese.17.28.20221-en 10.1111/mve.12083 10.1186/s13071-020-04285-x 10.1038/s41598-021-85411-2 10.1371/journal.pntd.0005294 10.1038/s41426-018-0195-x 10.1016/j.actatropica.2014.10.013 10.1186/s13071-019-3467-y 10.1111/1469-0691.12189 10.1603/ME13204 10.1603/0022-2585-37.1.108 10.1093/jmedent/34.6.745 10.1089/vbz.2015.1821 10.1603/0022-2585-40.1.82 10.4269/ajtmh.2011.11-0078 10.1186/s13071-018-2959-5 10.1016/j.jviromet.2004.01.007 10.5694/j.1326-5377.1999.tb127878.x 10.1016/j.meegid.2011.08.013 10.1038/s42003-020-1046-6 10.1016/S1473-3099(17)30024-5 10.1371/journal.pntd.0008320 10.1007/s00436-013-3564-3 10.1371/journal.pntd.0006435
Parasites & Vectors; Hernández-Triana LM, Folly AJ et. al.
Jun 17th, 2022 - Japanese encephalitis virus (JEV) is the principal cause of mosquito-borne encephalitis in human populations within Asia. If introduced into new geographic areas, it could have further implications for public and animal health. However, potential ...
Journal of Clinical Virology : the Official Publication O... Tandale BV, Tomar SJ et. al.
Jun 11th, 2022 - We enhanced surveillance of hospitalizations of all ages for acute encephalitis syndrome (AES) along with infectious aetiologies, including the Japanese encephalitis virus (JEV). From October 2018 to September 2020, we screened neurological patien...
PLoS Pathogens; Yu X, Tong L et. al.
Jun 10th, 2022 - Arboviruses are etiological agents of various severe human diseases that place a tremendous burden on global public health and the economy; compounding this issue is the fact that effective prophylactics and therapeutics are lacking for most arbov...
Guidelines 2 results
MMWR. Morbidity and Mortality Weekly Report;
Nov 15th, 2013 - On June 19, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to includ...
MMWR. Recommendations and Reports : Morbidity and Mortali... Fischer M, Lindsey N et. al.
Mar 13th, 2010 - This report updates the 1993 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the prevention of Japanese encephalitis (JE) among travelers (CDC. Inactivated Japanese encephalitis virus vaccine: recommendations...
Drugs 1 results see all →
Clinicaltrials.gov 67 results
Mar 28th, 2022 - Study participants who are previously immunized with JE-CV vaccine will receive a booster dose of the JE-CV vaccine and will be followed up for 5 years for immunogenicity. The control (JE-CV naïve) participants will receive either one dose of JE-C...
Mar 28th, 2022 - Study participants will be enrolled by age group and will each receive one injection of IMOJEV® on Day 0 given as primary vaccination. They will be assessed for immunogenicity and safety, post-vaccination.
Mar 9th, 2022 - The clinical study used randomized, blind method, commercialize inactivated Japanese encephalitis vaccine as control. In Infants at 6-23 months of age were injected with experimental vaccine with 0,7 days and 0,28 days vaccination schedule to eval...
Jul 27th, 2021 - Open-label, randomized, active controlled Phase 3 study in children aged ≥ 2 months to < 18 years. Subjects aged ≥ 2 months to < 12 months were randomized in a 2:1 ratio to receive IC51 (0.25 ml dose) or Prevnar® as a safety comparator. Children a...
Apr 1st, 2021 - Based on the retrospective registry in Zhejiang Provincial Immunization Information System, healthy children aged 6 years from 5 cohorts were included according to their previous immunization schedules on JE: 3 doses of JEV-I (Group 1), JEV-L+ JEV...
News 51 results
Marissa Lobl, BS, Taylor Kay Thieman, BS et. al.
May 11th, 2021 - What is West Nile virus? How is it contracted, and who can become infected? West Nile virus (WNV) is a single-stranded RNA virus of the Flaviviridae family and Flavivirus genus, a lineage that also includes the yellow fever, dengue, Zika, Japanese.
Apr 7th, 2021 - PARIS (Reuters) - Valneva on Tuesday reported positive results for its COVID-19 vaccine in early stage clinical trials and said it planned to launch a Phase Three trial this month. The French drugmaker, whose shot uses the technology behind its li...
Nov 18th, 2020 - Editor's note, 25 November 2020: The reader poll has now closed. The results are published here Novavax Novavax expects to fully enrol phase 3 clinical trials of its NVX-CoV2373 candidate in the UK by the end of November. Trials in the US and Mexi...
Jerry Fan, MD, Hameed Ali, DO
Sep 4th, 2020 - A renewed effort to vaccinate service members fighting the global war on terrorism has brought new diagnostic challenges. Vaccinations not generally given to the public are routinely given to service members when they deploy to various parts of th.
Nov 26th, 2019 - (Reuters Health) - Many common travel vaccines don't have known safety risks for pregnant women, although a research review also suggests that evidence is limited for some inoculations. Researchers examined data from trials of common travel vaccin...